You are currently viewing a new version of our website. To view the old version click .

Molecular Research on Pathophysiology of Multiple Sclerosis and Neuroinflammation

This special issue belongs to the section “Molecular Neurobiology“.

Special Issue Information

Dear Colleagues,

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). Inflammatory demyelination of white matter in the CNS, characterized by acute phases alternating remission phases, is the main pathological feature of MS and of experimental autoimmune encephalomyelitis, which is its animal model equivalent, regarded as reliable. A distinctive feature of inflammatory demyelination is the complex coordination of innate and adaptive immune processes. Recovery from nerve damage and degeneration after neuroinflammation at present is very difficult, probably owing to a lack of effective remedies. Thus, a better comprehension of the physiopathological processes underlying neuroinflammation during the different phases characterizing MS would help us to understand the disease and, as a result, identify efficacious therapeutic targets and, in any case, therapeutic strategies useful to counteract the disease.

The present Special Issue aims to collate original contributions and reviews exploring pathways that will lead us to the above goal. Both experimental pre-clinical studies and clinical studies involving patients will be considered, including those investigating the use of biomarkers.

Prof. Dr. Fabrizio Michetti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • multiple sclerosis (MS)
  • autoimmune diseases
  • encephalomyelitis
  • neuroinflammation
  • central nervous system (CNS)
  • autoimmunity and neurodegeneration
  • molecular basis of immune mechanisms

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067